
Last updated: 2026-10-12 08:04:20. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.
Cellyan Biotechnology Co., Ltd (HKPD) operates in the -- sector and is listed on NASDAQ. The stock is currently priced at $0,11, with a market capitalization of $5,52M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $0,10 to $1,72. This page covers its latest market performance, valuation, price trends and company information.
$5,52M | |
$0,11 | |
$3,79 | |
$0,10 | |
$0,11 | |
2,44K | |
3,84M | |
-- | |
$1,72 | |
$0,10 | |
-- | |
-- |
Cellyan Biotechnology Co., Ltd (HKPD) is trading at $0,11 in pre-market trading as of 2026-10-12 08:03:00, down 0,89% ($0,00) from the previous close of $0,11
Pre-market trading shows how investors are pricing HKPD before the regular session opens. The current pre-market price is below the previous close, indicating cautious early trading sentiment.
Over the past seven days, Cellyan Biotechnology Co., Ltd (HKPD) moved from $0,11 to $0,11, representing a decline of 0,72% ($0,00).
The stock traded between $0,10 and $0,12 during the period. The latest price is near the upper end of the 7-day range, indicating moderate downward.
The average daily volume was 731,39 thousand shares, up versus the previous seven-day period, indicating higher trading activity.
Position in Range: 1,0%
HKPD is currently trading at $0,11, placing it 1,0% of the way from its 52-week low of $0,10 to its 52-week high of $1,72. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Cellyan Biotechnology Co Ltd is an integrated pharmaceutical cross-border e-commerce supply chain service provider with a professional team and related pharmaceutical storage facilities in Hong Kong. It operates through two main categories: OTC pharmaceutical cross-border e-commerce supply chain services, referred to as the Supply Chain Services division, and OTC pharmaceutical cross-border procurement and distribution, referred to as the Procurement and Distribution division. Its main business provides one-stop services for merchants engaged in cross-border pharmaceutical e-commerce, including OTC wholesale, import and export, warehousing, packaging, customs clearance and delivery to final destinations, forming a closed loop of pharmaceutical cross-border e-commerce supply chain.
| Employees | 11 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of Cellyan Biotechnology Co., Ltd (HKPD) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.